Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Funded Studies: 2014


AUSTRALIA

Cassandra Szoeke, Ph.D.
University of Melbourne
Melbourne, Australia
The Women’s Healthy Ageing Project - Cognition Study
New Investigator Research Grant — $100,000 over two years

CANADA

Patricia Belchior, Ph.D.
McGill University
Montreal, Canada
Sustaining and Retraining Attention in Individuals with MCI
New Investigator Research Grant — $99,957 over two years

Mallar Chakravarty, Ph.D.
Centre for Addiction and Mental Health
Toronto, Canada
Interpreting Disease Heterogeneity in Alzheimer’s and Parkinson’s Disease
Biomarkers Across Neurodegenerative Diseases — $149,600 over two years

Alain Dagher, M.D.
McGill University
Montreal, Canada
Brain Networks as Targets of Neurodegeneration in Parkinson’s and Alzheimer’s Disease
Biomarkers Across Neurodegenerative Diseases — $149,998 over two years

Jesse Hoey, Ph.D.
University of Waterloo
Waterloo, Canada
Affective and Cognitive Technologies for AssisTance in the HOME (ACT@HOME)
Everyday Technologies for Alzheimer’s Care — $199,870 over three years

Chantelle F. Sephton, Ph.D.
Université Laval
Quebec City, Canada
FUS in Synaptic Function and Frontotemporal Lobar Degeneration
New Investigator Research Grant — $100,000 over two years

FRANCE

Jean-Charles Lambert, Ph.D.
Institut Pasteur de Lille
Lille, France
Involvement of BIN1 in the Alzheimer's Pathophysiological Process
IIRG: Biological Underpinnings of Genetic Risk Factors in Alzheimer's disease — $250,000 over three years

IRELAND

Barry Boland, Ph.D.
University College Cork
Cork, Ireland
Biomarkers of Impaired Lysosomal Flux in Alzheimer's Disease
New Investigator Research Grant — $100,000 over two years

ITALY

Elena Marcello, Ph.D.
University of Milan
Milan, Italy
Development of Innovative Tools for Alzheimer's Disease Therapy
New Investigator Research Grant — $100,000 over two years

Cristian Ripoli, Ph.D.
Università Cattolica del Sacro Cuore
Rome, Italy
Intraneuronal Binding Partners of Amyloid-ß Protein
New Investigator Research Grant — $96,800 over two years

Simona Tomaselli, Ph.D.
CNR Institute for Macromolecular Studies
Milan, Italy
Structural Insights on Oligomers of Aβ Peptides in the Presence of PrPC
New Investigator Research Grant — $100,000 over two years

NETHERLANDS

Mohammad A. Ikram, M.D., Ph.D.
Erasmus Medical Center
Rotterdam, Netherlands
Gait Dysfunction as a Pre-Clinical Sign of Alzheimer's Disease
New Investigator Research Grant — $99,971 over two years

UNITED KINGDOM

Katie Lunnon, Ph.D.
University of Exeter
Exeter, United Kingdom
The Role of 5-Hydroxymethylation in the Alzheimer’s Disease Brain
New Investigator Research Grant — $99,072 over two years

UNITED STATES

Alabama

Erik Roberson, M.D., Ph.D.
University of Alabama at Birmingham
Birmingham, Alabama
BIN1 and Tau Interactions Regulating Neuronal Calcium
IIRG: Biological Underpinnings of Genetic Risk Factors in Alzheimer's disease — $249,999 over three years

Arizona

Pengcheng Han, Ph.D.
Barrow Neurological Institute - St. Joseph Medical Center
Phoenix, Arizona
PACAP Deficit and the Pathogenesis of Alzheimer's Disease
New Investigator Research Grant — $100,000 over two years

Diego F. Mastroeni, Ph.D.
Banner Sun Health Research Institute
Sun City, Arizona
Profiling the Gliome in Alzheimer’s Disease
New Investigator Research Grant — $100,000 over two years

California

Michelle Arkin, Ph.D.
University of California, San Francisco
San Francisco, California
Inhibitors of Caspase-6 as Potential Alzheimer’s Disease Therapeutics
IIRG: Discovery-Validation of Therapeutic Targets for Developing Novel Interventions of Alzheimer's disease — $250,000 over three years

Mathew M. Blurton-Jones, Ph.D.
University of California, Irvine
Irvine, California
Examining the Role of TREM2 in AD Pathogenesis with iPSC-Derived Microglia
IIRG: Biological Underpinnings of Genetic Risk Factors in Alzheimer's disease — $250,000 over three years

Michael C. Donohue, Ph.D.
University of California, San Diego
San Diego, California
Estimating Long-Term Disease Trajectories
Biomarkers Across Neurodegenerative Diseases — $148,843 over two years

Boris Gutman, Ph.D.
University of Southern California
Los Angeles, California
Subcortical Shape Analysis for Joint Biomarker Discovery
Biomarkers Across Neurodegenerative Diseases — $150,000 over two years

Amy Jak, Ph.D.
University of California, San Diego
San Diego, California
Impact of Combined Behavioral Interventions on Cognitive Outcomes in MCI
IIRG: Non-Pharmacological Strategies to Ameliorate Symptoms of Alzheimer's Disease and Dementia — $246,978 over three years

Gautam Prasad, Ph.D.
University of Southern California
Los Angeles, California
Degeneration of the Human Connectome: Brain Networks in ADNI and PPMI
Biomarkers Across Neurodegenerative Diseases — $150,000 over two years

Eli Puterman, Ph.D.
University of California, San Francisco
San Francisco, California
Improving Caregivers’ Daily Lives with Exercise: A Randomized Study
New Investigator Research Grant — $100,000 over two years

Norbert Schuff, Ph.D.
University of California, San Francisco
San Francisco, California
Variations in Brain Functional Complexity Across Neurodegeneration
Biomarkers Across Neurodegenerative Diseases — $150,000 over two years

Shauna Yuan, M.D.
University of California, San Diego
San Diego, California
“In-vitro Clinical Trial” with GSM for the Treatment of FAD Carriers
New Investigator Research Grant — $100,000 over two years

Connecticut

Jaime Grutzendler, M.D.
Yale University School of Medicine
New Haven, Connecticut
The Role of Angiophagy in Alzheimer's Disease Pathology
IIRG: Role of Vascular Metabolic Factors in Pathogenesis of Alzheimer's Disease and Related Dementia — $250,000 over three years

Stephen M. Strittmatter, M.D., Ph.D.
Yale University School of Medicine
New Haven, Connecticut
Signaling by Aß Oligomer in the Post-Synaptic Density
Zenith Fellows Award — $450,000 over three years

Florida

Jie Cui, Ph.D.
The Roskamp Institute Inc.
Sarasota, Florida
Can Aromatase Inhibitors Increase the Risk of AD in Breast Cancer Patients?
New Investigator Research Grant — $100,000 over two years

John R. Gilbert, Ph.D.
University of Miami
Miami, Florida
Identification of Mutations and Transcription in LOAD GWAS Regions
IIRG: Biological Underpinnings of Genetic Risk Factors in Alzheimer's disease — $249,336 over three years

Takahisa Kanekiyo, M.D., Ph.D.
Mayo Clinic Jacksonville
Jacksonville, Florida
ApoE and LRP1 in Neuronal Aß Clearance
New Investigator Research Grant — $99,999 over two years

Yongjie Zhang, Ph.D.
Mayo Clinic Jacksonville
Jacksonville, Florida
Mechanism of DPR Protein-Induced Cell Death
New Investigator Research Grant — $100,000 over two years

Illinois

Scott Brady, Ph.D.
University of Illinois, Chicago
Chicago, Illinois
Signaling Pathways, Molecular Motors and Cell-Specificity in Alzheimer's Disease
Zenith Fellows Award — $450,000 over three years

Kumar B. Rajan, Ph.D.
Rush University Medical Center
Chicago, Illinois
Role of Activities on Genetic Risk of Neurodegeneration by Race/Ethnicity
New Investigator Research Grant — $99,914 over two years

Indiana

Shannon L. Risacher, Ph.D.
Indiana University
Indianapolis, Indiana
Visual Dysfunction and Amyloid in Preclinical and Prodromal AD
New Investigator Research Grant — $100,000 over two years

Kentucky

Jose F. Abisambra, Ph.D.
University of Kentucky
Lexington, Kentucky
The Impact of Tau on Ribosomal Function in AD
New Investigator Research Grant — $100,000 over two years

Massachusetts

Rhoda Au, Ph.D.
Boston University
Boston, Massachusetts
Framingham Cognitive Aging Study: Impact of Vascular Metabolic Risk Factors
IIRG: Role of Vascular Metabolic Factors in Pathogenesis of Alzheimer's Disease and Related Dementia — $249,459 over three years

Elizabeth Bradshaw, Ph.D.
Brigham and Women's Hospital, Inc.
Boston, Massachusetts
Genetics, Function and Small Molecules: Targeting the CD33 AD Locus
IIRG: Discovery-Validation of Therapeutic Targets for Developing Novel Interventions of Alzheimer's disease — $250,000 over three years

Angela Gutchess, Ph.D.
Brandeis University
Waltham, Massachusetts
Improving Memory in aMCI with Self-Referencing
New Investigator Research Grant — $100,000 over two years

Tsuneya Ikezu, M.D., Ph.D.
Boston University
Boston, Massachusetts
Exosome Pathway as a Novel Therapeutic Target of Tauopathy
IIRG: Discovery-Validation of Therapeutic Targets for Developing Novel Interventions of Alzheimer's disease — $250,000 over three years

Pei-Jung Lin, Ph.D.
Tufts Medical Center
Boston, Massachusetts
Nationwide Frequency and Costs of Preventable Hospitalizations in AD
New Investigator Research Grant — $100,000 over two years

Kun Ping Lu, M.D., Ph.D.
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Validation of cis-Tau as a Therapeutic Target for Alzheimer's Disease
IIRG: Discovery-Validation of Therapeutic Targets for Developing Novel Interventions of Alzheimer's disease — $249,999 over three years

Gail Musen, Ph.D.
Joslin Diabetes Center
Boston, Massachusetts
Type 2 Diabetes and Risk for Alzheimer's Disease: Effect of Exercise
IIRG: Non-Pharmacological Strategies to Ameliorate Symptoms of Alzheimer's Disease and Dementia — $250,000 over three years

Thor Stein, M.D., Ph.D.
Bedford VA Research Corporation, Inc.
Boston, Massachusetts
Genetic Risk Factors Underlying Chronic Trauma and AD Pathology
New Investigator Research Grant — $99,954 over two years

Benjamin Wolozin, M.D., Ph.D.
Boston University
Boston, Massachusetts
It Takes TIA to Tangle: The Role of RNA Binding Proteins in AD
Zenith Fellows Award — $450,000 over three years

Michigan

Peter J. H. Scott, Ph.D.
University of Michigan
Ann Arbor, Michigan
Lead Optimization of High Affinity Radiotracers for PET Imaging of Tau
New Investigator Research Grant — $99,839 over two years

Carey W. Sherman, Ph.D.
University of Michigan
Ann Arbor, Michigan
Technology-Assisted Intervention for Remarried and Stepfamily Caregivers
New Investigator Research Grant — $99,976 over two years

Missouri

Carlos Cruchaga, Ph.D.
Washington University School of Medicine
St. Louis, Missouri
Genetics, Biomarkers and Mendelian Randomization to Identify Common Pathways
Biomarkers Across Neurodegenerative Diseases — $134,059 over two years

Erik S. Musiek, M.D., Ph.D.
Washington University School of Medicine
St. Louis, Missouri
The Circadian Clock as a Therapeutic Target for Alzheimer’s Disease
New Investigator Research Grant — $100,000 over two years

New Jersey

Qian Cai, M.D., Ph.D.
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Regulation of Synaptic Aß Generation via BACE1 Retrograde Transport in AD
New Investigator Research Grant — $100,000 over two years

Radoslaw Dobrowolski, Ph.D.
Rutgers, The State University -Newark Campus
Newark, New Jersey
Dysregulation of Molecular Clearance Pathways in Alzheimer’s Disease
New Investigator Research Grant — $100,000 over two years

New York

Dongming Cai, M.D., Ph.D.
Icahn School of Medicine at Mount Sinai
New York, New York
Development of Novel Therapies Targeted at Abeta Clearance
New Investigator Research Grant — $100,000 over two years

Elizabeth Guerrero-Berroa, Ph.D.
Icahn School of Medicine at Mount Sinai
New York, New York
Haptoglobin, Glycemic Control, and Cognitive Decline in Type 2 Diabetes
Mentored New Investigator Research Grant to Promote Diversity — $149,988 over three years

Roger Lefort, Ph.D.
Columbia University Medical Center
New York, New York
Targeting RhoA Signaling as a Therapeutic Strategy for Alzheimer's Disease
New Investigator Research Grant to Promote Diversity — $100,000 over two years

Feng Lin, Ph.D.
University of Rochester
Rochester, New York
Differentiating Neurophysiological Stress Regulation in Alzheimer's Disease
New Investigator Research Grant — $100,000 over two years

Rocio Perez-Gonzalez, Ph.D.
The Nathan S. Kline Institute for Psychiatric Research
Orangeburg, New York
A Pathogenic Role for APP-CTFs-Enriched Exosomes in the Brain
New Investigator Research Grant — $100,000 over two years

Agueda Rostagno, Ph.D.
New York University School of Medicine
New York, New York
CAA, Mitochondrial Dysfunction, and the Neurovascular Unit
Zenith Fellows Award — $450,000 over three years

R. Nathan Spreng, Ph.D.
Cornell University
Ithaca, New York
Dynamic Brain Network Changes in Healthy Aging and Alzheimer's Disease
New Investigator Research Grant — $99,997 over two years

North Carolina

Todd J. Cohen, Ph.D.
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
A Pathogenic Role for Tau Acetylation in Alzheimer's Disease
New Investigator Research Grant — $99,722 over two years

Ohio

Jalayne Arias, J.D.
Cleveland Clinic Foundation
Cleveland, Ohio
Legal, Ethical, & Social Analysis of Preclinical Biomarker Tests in AD
Mentored New Investigator Research Grant to Promote Diversity — $150,000 over three years

Bruce T. Lamb, Ph.D.
Cleveland Clinic Foundation
Cleveland, Ohio
The Role of TREM2 on Inflammatory Monocytes in Alzheimer’s Disease
IIRG: Biological Underpinnings of Genetic Risk Factors in Alzheimer's disease — $250,000 over three years

Jagan A. Pillai, Ph.D.
Cleveland Clinic Foundation
Cleveland, Ohio
Inflammatory Biomarkers in Rapidly Progressive Alzheimer’s Disease
New Investigator Research Grant — $99,983 over two years

Xinglong Wang, Ph.D.
Case Western Reserve University
Cleveland, Ohio
The Role of DLP1 Phosphorylation in Alzheimer’s Disease
New Investigator Research Grant — $100,000 over two years

Daniel W. Wesson, Ph.D.
Case Western Reserve University
Cleveland, Ohio
Impact of Upstream Neurodegeneration on Downstream Cortical Function
New Investigator Research Grant — $100,000 over two years

Oklahoma

Carrie Ciro, Ph.D.
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
High-Dose, Mass Practice Intervention to Reduce ADL Disability in Dementia
New Investigator Research Grant — $99,967 over two years

Pennsylvania

Kirk Erickson, Ph.D.
University of Pittsburgh
Pittsburgh, Pennsylvania
Influence of African Dance on Neurocognitive Function
IIRG: Non-Pharmacological Strategies to Ameliorate Symptoms of Alzheimer's Disease and Dementia — $250,000 over three years

Corey T. McMillan, Ph.D.
University of Pennsylvania
Philadelphia, Pennsylvania
Biomarkers for Personalized Treatment of Neurodegenerative Spectrum Disease
Biomarkers Across Neurodegenerative Diseases — $150,000 over two years

Alberto L. Vazquez, Ph.D.
University of Pittsburgh
Pittsburgh, Pennsylvania
Physiological Basis of Brain Connectivity Reductions in AD
Mentored New Investigator Research Grant to Promote Diversity — $149,998 over three years

South Carolina

Saeid Taheri, Ph.D.
Medical University of South Carolina
Charleston, South Carolina
Contribution of BBB Pathologies to Alzheimer's Disease and Dementia
IIRG: Role of Vascular Metabolic Factors in Pathogenesis of Alzheimer's Disease and Related Dementia — $249,620 over three years

Tennessee

Swati Rane, Ph.D.
Vanderbilt University Medical Center
Nashville, Tennessee
Cortical and Functional Distinctions in Alzheimer's and Parkinson's Disease
Biomarkers Across Neurodegenerative Diseases — $150,000 over two years

Texas

Laura L. Colgin, Ph.D.
University of Texas at Austin
Austin, Texas
Does Theta-Gamma Stimulation Improve Memory in Alzheimer's Disease Mice?
New Investigator Research Grant — $100,000 over two years

Rebecca L. Cunningham, Ph.D.
University of North Texas Health Science Center
Fort Worth, Texas
Sleep Apnea, Oxidative Stress, and Testosterone on Neuroinflammation
New Investigator Research Grant — $100,000 over two years

Heidi Rossetti, Ph.D.
UT Southwestern Medical Center
Dallas, Texas
Montreal Cognitive Assessment for Detection of MCI in African Americans
New Investigator Research Grant — $99,858 over two years

Joshua Shulman, M.D., Ph.D.
Baylor College of Medicine
Houston, Texas
Genome Instability as a Novel Link between Aging and Alzheimer’s Disease
New Investigator Research Grant — $100,000 over two years

Utah

Katherine Supiano, Ph.D.
University of Utah
Salt Lake City, Utah
Complicated Grief Group Therapy for Bereaved Dementia Caregivers
New Investigator Research Grant — $99,999 over two years

Washington

Douglas M. Fowler, Ph.D.
University of Washington
Seattle, Washington
Large-Scale Mutagenesis to Probe Aß Aggregation and Chaperone Interactions
New Investigator Research Grant — $100,000 over two years

Ellen McGough, Ph.D.
University of Washington
Seattle, Washington
Neural Imaging and Function in Early Stages of Alzheimer's Disease
New Investigator Research Grant — $99,946 over two years

Washington DC

Charbel Moussa, Ph.D.
Georgetown University
Washington DC
Nilotinib Effects on Parkin-Mediated p-Tau Clearance
New Investigator Research Grant — $99,931 over two years

Wisconsin

Ozioma C. Okonkwo, Ph.D.
University of Wisconsin-Madison
Madison, Wisconsin
Aerobic Exercise for AD Prevention in At-Risk Middle-Aged Adults
New Investigator Research Grant to Promote Diversity — $100,000 over two years

Back to top